Status:
COMPLETED
Epidemiological Study of the Markers of Aging in the Cohort of Patient HIV in Brest
Lead Sponsor:
University Hospital, Brest
Conditions:
Aging, Premature
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: HIV pathology has been associated with accelerated aging of the infected organism, with no known knowledge of virus, immunosuppression, immune response stimulation, antiretroviral toxicity,...
Detailed Description
Rational: HIV pathology has been associated with an accelerated aging of the infected organism, without anyone knowing how to do it: * the direct toxicity of the virus; * CD4 immuno-depletion and it...
Eligibility Criteria
Inclusion
- HIV positive persons followed in Internal Medicine departement of Brest University Hospital
Exclusion
- opposition of the study
- \<18 ans
Key Trial Info
Start Date :
January 8 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT06554210
Start Date
January 8 2017
End Date
December 31 2017
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internal Medicine Department of University Hospital
Brest, France, 29200